[A case of polyneuropathy after COVID-19 vaccine]

Rinsho Shinkeigaku. 2022 Jul 29;62(7):558-562. doi: 10.5692/clinicalneurol.cn-001750. Epub 2022 Jun 24.
[Article in Japanese]

Abstract

A 43-year-old-woman developed paresthesia, weakness of limbs, dysphagia and deep sensory impairment 12 days after vaccination of Pfizer COVID-19 vaccine. Her deep tendon reflexes were absent and cerebrospinal fluid showed normal cell counts and protein level. Anti-ganglioside antibodies were negative, and F wave frequency was decreased in nerve conduction studies. We diagnosed her as immune mediated polyneuropathy caused by COVID-19 vaccine, and plasma exchange improved her symptoms. Compared with Guillain-Barré syndrome and polyneuropathy following COVID-19 infection and COVID-19 vaccination, deep sensory impairment was the most characteristic of this case. We supposed that non-antigen specific mechanism played an important role in the pathogenesis of this case.

Keywords: COVID-19; Guillain–Barré syndrome; SARS-CoV-2; polyneuropathy; vaccination.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Female
  • Gangliosides
  • Guillain-Barre Syndrome* / diagnosis
  • Humans
  • Plasma Exchange / adverse effects

Substances

  • COVID-19 Vaccines
  • Gangliosides